EE04741B1 - Sigade sigimis- ja hingamissündroomi vaktsiin - Google Patents

Sigade sigimis- ja hingamissündroomi vaktsiin

Info

Publication number
EE04741B1
EE04741B1 EE9800267A EE9800267A EE04741B1 EE 04741 B1 EE04741 B1 EE 04741B1 EE 9800267 A EE9800267 A EE 9800267A EE 9800267 A EE9800267 A EE 9800267A EE 04741 B1 EE04741 B1 EE 04741B1
Authority
EE
Estonia
Prior art keywords
vaccine
respiratory syndrome
porcine reproductive
porcine
reproductive
Prior art date
Application number
EE9800267A
Other languages
English (en)
Estonian (et)
Other versions
EE9800267A (et
Inventor
A. Hesse Richard
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04741(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of EE9800267A publication Critical patent/EE9800267A/xx
Publication of EE04741B1 publication Critical patent/EE04741B1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
EE9800267A 1996-03-01 1997-02-26 Sigade sigimis- ja hingamissündroomi vaktsiin EE04741B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01
PCT/US1997/002562 WO1997031651A1 (en) 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine

Publications (2)

Publication Number Publication Date
EE9800267A EE9800267A (et) 1999-02-15
EE04741B1 true EE04741B1 (et) 2006-12-15

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800267A EE04741B1 (et) 1996-03-01 1997-02-26 Sigade sigimis- ja hingamissündroomi vaktsiin

Country Status (19)

Country Link
EP (1) EP0894007A1 (de)
JP (1) JP3135069B2 (de)
KR (1) KR100297537B1 (de)
CN (1) CN1165342C (de)
AR (1) AR006023A1 (de)
AU (1) AU2277497A (de)
BG (1) BG64693B1 (de)
BR (1) BR9708443B1 (de)
CA (1) CA2248182C (de)
CO (1) CO4600644A1 (de)
CZ (1) CZ273798A3 (de)
EE (1) EE04741B1 (de)
HU (1) HUP9901958A3 (de)
MY (1) MY115070A (de)
PL (1) PL328627A1 (de)
RU (1) RU2187333C2 (de)
SK (1) SK119498A3 (de)
WO (1) WO1997031651A1 (de)
ZA (1) ZA971663B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
EP0839912A1 (de) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren
NZ501264A (en) 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
DK1183332T3 (da) 1999-04-22 2010-09-06 Us Agriculture Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
BRPI0510928A (pt) 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
UA95778C2 (ru) 2005-06-24 2011-09-12 Риджентс Оф Зе Юниверсити Оф Миннесота Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
CN101612395B (zh) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 一种培养敏感细胞生产蓝耳病疫苗的方法
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
WO2012110490A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR101300528B1 (ko) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 액티노바실러스 플루로뉴모니애 감염 방지 및 처치용 조성물
EP2968513A2 (de) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Prrs-virus, zusammensetzungen, impfstoff und verfahren zur verwendung
CZ309704B6 (cs) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transportní médium pro transport a skladování virů
EP4012025A1 (de) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transportmedium für nukleinsäuren- und/oder proteinhaltige proben

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
JPH07501049A (ja) * 1991-10-14 1995-02-02 アクゾ・ノベル・エヌ・ベー ブタ生殖・呼吸系症候群ワクチン及び診断方法
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2152304T3 (es) * 1993-02-08 2001-02-01 Bayer Ag Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.
ES2074950B1 (es) * 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
ES2165405T3 (es) * 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
MY115070A (en) 2003-03-31
BR9708443B1 (pt) 2012-06-12
BR9708443A (pt) 1999-08-03
CN1165342C (zh) 2004-09-08
WO1997031651A1 (en) 1997-09-04
EE9800267A (et) 1999-02-15
EP0894007A1 (de) 1999-02-03
AR006023A1 (es) 1999-07-21
CA2248182C (en) 2004-04-20
AU2277497A (en) 1997-09-16
MX9807083A (es) 1998-12-31
BG64693B1 (bg) 2005-12-30
RU2187333C2 (ru) 2002-08-20
HUP9901958A2 (hu) 1999-10-28
CN1216922A (zh) 1999-05-19
JP3135069B2 (ja) 2001-02-13
HUP9901958A3 (en) 2000-04-28
PL328627A1 (en) 1999-02-15
SK119498A3 (en) 1999-07-12
JPH11506122A (ja) 1999-06-02
BG102809A (en) 1999-05-31
KR19990087432A (ko) 1999-12-27
KR100297537B1 (ko) 2001-10-26
CO4600644A1 (es) 1998-05-08
CZ273798A3 (cs) 1999-02-17
ZA971663B (en) 1997-08-26
CA2248182A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
DK102894A (da) Vaccine mod det porcine reproduktions- og respirationssyndrom
DE69505325D1 (de) Tracheale Atemwegvorrichtung
ATE209053T1 (de) Inhaliervorrichtung
HU9602421D0 (en) Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
BR9711853A (pt) Vacinas
EE04741B1 (et) Sigade sigimis- ja hingamissündroomi vaktsiin
DE69725286D1 (de) Keratoplastik-vorrichtung
DE69716012D1 (de) Kehlkopfmaske
DE69736084D1 (de) Nasenmaske und Polsterung dafür
KR970702320A (ko) 퍼플루오로엘라스토머 경화(perfuloroelastomer curing)
DE69501811D1 (de) Luftkissenvorrichtung
DE69216277D1 (de) Evakuierungssystem und -verfahren
AU7960598A (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
DE69400778D1 (de) Integriertes Luftverdichtungssystem
EE9800462A (et) Komponendid inhaleerimisseadmetele
ATA44596A (de) Selbsttätig arbeitende atmungshilfeeinrichtung
KR970030435U (ko) 에어 브리딩 장치
KR980001810U (ko) 자동으로 절첩되는 자동차의 발받침대
IT230068Y1 (it) Maschera-filtro per anestesia e rianimazione.
DK9600247U4 (da) Nasal dilatationsindretning
DK44396A (da) Nasal dilatationsindretning
KR970703417A (ko) 유두종 바이러스 백신(Papillomavirus vaccines)
KR960021472U (ko) 자동차 의자용 발걸이장치
FIU960438U0 (fi) Laite aineen antamiseksi nenän kautta

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name